ES2084478T3 - Formas de dosificacion que tienen liberacion prolongada del ingrediente activo. - Google Patents

Formas de dosificacion que tienen liberacion prolongada del ingrediente activo.

Info

Publication number
ES2084478T3
ES2084478T3 ES93810066T ES93810066T ES2084478T3 ES 2084478 T3 ES2084478 T3 ES 2084478T3 ES 93810066 T ES93810066 T ES 93810066T ES 93810066 T ES93810066 T ES 93810066T ES 2084478 T3 ES2084478 T3 ES 2084478T3
Authority
ES
Spain
Prior art keywords
dosage forms
weight
active ingredient
prolonged release
calcium antagonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93810066T
Other languages
English (en)
Inventor
Sabine Compassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siegfried Pharma AG
Original Assignee
Siegfried Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Pharma AG filed Critical Siegfried Pharma AG
Application granted granted Critical
Publication of ES2084478T3 publication Critical patent/ES2084478T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

SE PROPONE UNA FORMA DE DOSIFICACION FARMACEUTICA DISPONIENDO DE UNA RELACION DE LIBERACION LINEAL DEL ORDEN DE 0 PARA ADMINISTRACION ORAL DE UNA VEZ AL DIA DE 20 PINA O DE OTRO ANTAGONISTA CALCICO DEL TIPO DE LA DIHIDROPIRIDINA, CARACTERIZADO MEDIANTE UNA MATRIZ HOMOGENEA CONTENIENDO DE 2 DE UN PESO MOLECULAR MEDIO DE 20.000 DE UN ANTAGONISTA CALCICO DEL TIPO DE LA DIHIDROPIRIDINA, ASI COMO EXCIPIENTES ACOSTUMBRADOS COMPATIBLES CON LA FORMULACION, TALES COMO CONTROLADORES DE LIBERACION LIPOFILICOS O HIDROFILICOS, SUSTANCIAS DE RELLENO, AGENTES DE REGULACION DE FLUJO, LUBRICANTES Y, OPCIONALMENTE, RECUBRIDORES DE PELICULA.
ES93810066T 1992-02-17 1993-02-03 Formas de dosificacion que tienen liberacion prolongada del ingrediente activo. Expired - Lifetime ES2084478T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46992 1992-02-17

Publications (1)

Publication Number Publication Date
ES2084478T3 true ES2084478T3 (es) 1996-05-01

Family

ID=4187725

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93810066T Expired - Lifetime ES2084478T3 (es) 1992-02-17 1993-02-03 Formas de dosificacion que tienen liberacion prolongada del ingrediente activo.

Country Status (6)

Country Link
EP (1) EP0557244B1 (es)
AT (1) ATE135214T1 (es)
DE (1) DE69301742T2 (es)
DK (1) DK0557244T3 (es)
ES (1) ES2084478T3 (es)
GR (1) GR3019314T3 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
NZ270439A (en) * 1995-02-02 1996-04-26 Bernard Charles Sherman Solid slow release pharmaceutical composition: carrier is polyethylene glycol and hydrophilic gel-forming polymer
NZ286451A (en) * 1996-04-24 1998-04-27 Bernard Charles Sherman Controlled release pharmaceutical composition containing granules comprising drug, water-insoluble polymer and meltable carrier
FR2901611B1 (fr) * 2006-05-24 2009-01-16 Airbus France Sas Dispositif de controle non destructif d'une piece par analyse de distribution du champ magnetique de fuite

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4571333A (en) * 1983-06-14 1986-02-18 Syntex (U.S.A.) Inc. Controlled release naproxen and naproxen sodium tablets
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
IE59540B1 (en) * 1987-01-09 1994-03-09 Elan Corp Sustained release capsule or tablet formulation
GB8722306D0 (en) * 1987-09-22 1987-10-28 Aps Research Ltd Sustained-release formulation
SI8810082A8 (en) * 1988-01-18 1995-12-31 Lek Tovarna Farmacevtskih Process for preparing new inclusion complex of nicardipine or its hydrochloride with beta-cyclodextrine
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung

Also Published As

Publication number Publication date
ATE135214T1 (de) 1996-03-15
DE69301742D1 (de) 1996-04-18
DE69301742T2 (de) 1996-08-14
DK0557244T3 (da) 1996-04-01
EP0557244B1 (en) 1996-03-13
GR3019314T3 (en) 1996-06-30
EP0557244A1 (en) 1993-08-25

Similar Documents

Publication Publication Date Title
RU93004469A (ru) Формы дозирования, обеспечивающие продленное выделение активного ингредиента
MX9300664A (es) Formas de dosis farmaceuticas que contienen liberacion prolongada de ingrediente activo.
GEP20012549B (en) Pharmaceutical Composition Containing Sumatriptan
NO20014724D0 (no) Pregelatinisert stivelse i en formulering med regulert frigivning
ES2191034T3 (es) Formulaciones de liberacion controlada para la liberacion de metoprolol durante 24 horas.
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
DE69616795D1 (de) Formulierungen mit gesteuerter freisetzung für schwerlösliche arzneistoffe
HK1077501A1 (en) Improved delivery of multiple doses of a methylphenidate drug
HUP9903734A2 (hu) Szabályozott felszabadulású, orális gyógyszerkészítmények és eljárás ezek előállítására
CA2123160A1 (en) Controlled release formulation
WO2000018447A3 (en) Multiplex drug delivery system suitable for oral administration
ATE277594T1 (de) Vorrichtungen um eine verlängerte medikamententherapie zu erreichen
DE69523438T2 (de) Orale metoprolol-dosisform des typs "einmal täglich"
CA2131350A1 (en) Sustained release drug formulation containing a tramadol salt
DE60005819D1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
PT797991E (pt) Formulacao com libertacao prolongada contendo venlafaxina
FI933274A0 (fi) Tvaerbundna, kvaevehaltiga vinylkopolymerer, foerfarande foer framstaellning av dessa samt anvaendning av dessa
ES2158101T3 (es) Formulaciones farmaceuticas efervescentes que contienen microcapsulas biodegradables de liberacion controlada.
DE69622739D1 (de) Pharmazeutische zubereitung mit schneller freisetzung
ATE253354T1 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
ES2084478T3 (es) Formas de dosificacion que tienen liberacion prolongada del ingrediente activo.
DE69723024D1 (de) Pharmazeutische Zusammensetzungen mit kontrollierter Freisetzung zur oralen Verabreichung enthaltend Nifedipin als Wirkstoff
GEP20043377B (en) Pharmaceutical Complex
CA2187153A1 (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 557244

Country of ref document: ES